Dihydroergotamine Mesylate and Oxybutynin Extended-Release Tablets
Determining the interaction of Dihydroergotamine Mesylate and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Oxybutynin Gel
- Dihydroergotamine Mesylate-Oxybutynin Oral Solution
- Dihydroergotamine Mesylate-Oxybutynin Syrup
- Dihydroergotamine Mesylate-Oxybutynin Tablets
- Dihydroergotamine Mesylate-Oxybutynin transdermal
- Dihydroergotamine Mesylate-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-Dihydroergotamine nasal
- Oxybutynin Extended-Release Tablets-Dihydroergotamine Nasal Spray
- Oxybutynin Extended-Release Tablets-Dilacor XR
- Oxybutynin Extended-Release Tablets-Dilantin
- Oxybutynin Extended-Release Tablets-Dilantin Infatabs
- Oxybutynin Extended-Release Tablets-Dilantin injection